Research advances on RPL11 in the regulation of cellular stress induced by ionizing radiation
10.13491/j.issn.1004-714X.2026.02.020
- VernacularTitle:RPL11在电离辐射诱导细胞应激调控中的研究进展
- Author:
Hongyu BAO
1
;
Yan LU
1
;
Chenyu ZHAO
1
;
Mingxuan BI
1
;
Jinghong FU
1
;
Yong ZHANG
1
;
Lian YU
1
;
Weiguo LI
1
Author Information
1. School of Preventive Medicine Sciences (Institute of Radiation Medicine), Shandong First Medical University (Shandong Academy of Medical Sciences), Jinan 250117, China.
- Publication Type:ReviewArticles
- Keywords:
Ribosomal protein;
Cell cycle;
Nucleolar stress;
RPL11;
Radiation
- From:
Chinese Journal of Radiological Health
2026;35(2):286-291
- CountryChina
- Language:Chinese
-
Abstract:
Radiotherapy is a cornerstone in the treatment of malignant tumors. It induces DNA damage through high-energy radiation, preferentially eliminating rapidly proliferating tumor cells. However, its clinical efficacy is often limited by tumor radioresistance and collateral damage to normal tissues. Consequently, elucidating the cellular response mechanisms to radiation stress and identifying key targets that can both sensitize tumor cells and protect normal tissues have become critical strategies for improving radiotherapy outcomes. Radiation stress triggers structural remodeling of the nucleolus, leading to the dissociation of certain ribosomal proteins from the ribosome and enabling them to acquire extra-ribosomal functions. Among these, RPL11 can be released and specifically binds to MDM2, thus inhibiting its E3 ubiquitin ligase activity, stabilizing p53, and mediating cell cycle arrest and apoptosis. The RPL11-MDM2-p53 pathway, acting as a signaling hub that links nucleolar dysfunction to cell fate determination, plays a pivotal role in maintaining genomic stability and regulating cellular responses to radiation. This review first introduces the basic characteristics of RPL11 and elucidates the molecular basis of radiation-induced ribosomal stress. It then outlines the core regulatory mechanisms of the cell cycle. On this basis, it focuses on the mechanisms by which radiation-induced RPL11 regulates the cell cycle and analyzes the specific effects of RPL11 on cell cycle. Furthermore, it discusses the role of the RPL11-MDM2-p53 pathway in cell cycle regulation. Finally, it explores the role of this pathway in maintaining genomic stability and determining cell fate, and highlights its potential value as a target for radiosensitization, aiming to provide new perspectives for enhancing tumor radiosensitivity and reducing damage to normal tissues.
